The results showed that upregulating PLAGL2 could alleviate pulmonary damage, reduce apoptosis, and inhibit the development of BPD by reactivating the HIF-1α/VEGF signaling pathway that had been suppressed by hyperoxia. The gene discussed is HIF1A; the disease is bronchopulmonary dysplasia.